KEQU — Kewaunee Scientific Cashflow Statement
0.000.00%
Last trade - 00:00- $144.42m
- $154.18m
- $203.76m
- 93
- 89
- 91
- 100
Annual cashflow statement for Kewaunee Scientific, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.62 | -3.61 | -6 | 1.36 | 19.1 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2.51 | 2.35 | 0.941 | 1.01 | 1.3 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.62 | -0.517 | -5.59 | -9.54 | 3.21 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 4.16 | 0.912 | -7.88 | -3.79 | 19.6 |
| Capital Expenditures | -2.46 | -2.4 | -1.91 | -4.15 | -4.37 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -2.46 | -2.4 | -1.91 | -4.15 | -4.37 |
| Financing Cash Flow Items | -0.324 | -0.108 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -7.46 | 1.98 | 11 | 14.9 | -3.01 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.94 | 0.516 | 1.16 | 6.92 | 12.1 |